Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer

Background. Breast cancer is the most common malignancy in women. Genetic risk factors associated with breast cancer incidence have been identified. Aims. This study is aimed at determining the association of XRCC3 Thr241Met (rs861539), XRCC4 G(-1394) T (rs6869366) DNA repair and BAX G(-248) A (rs46...

Full description

Saved in:
Bibliographic Details
Main Authors: Emre Ozoran, Fadime Didem Can Trabulus, Duygu Erhan, Bahadir Batar, Mehmet Guven
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2022/5817841
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553006241939456
author Emre Ozoran
Fadime Didem Can Trabulus
Duygu Erhan
Bahadir Batar
Mehmet Guven
author_facet Emre Ozoran
Fadime Didem Can Trabulus
Duygu Erhan
Bahadir Batar
Mehmet Guven
author_sort Emre Ozoran
collection DOAJ
description Background. Breast cancer is the most common malignancy in women. Genetic risk factors associated with breast cancer incidence have been identified. Aims. This study is aimed at determining the association of XRCC3 Thr241Met (rs861539), XRCC4 G(-1394) T (rs6869366) DNA repair and BAX G(-248) A (rs4645878), and BCL2 C(-938) A (rs2279115) apoptotic gene polymorphisms with breast cancer. Materials and Methods. Genetic analysis was performed using peripheral blood samples. Gene polymorphisms were detected by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. 175 patients and 158 healthy controls were enrolled in the study. Results. Breast cancer risk was 5.43 times more in individuals with AA genotype of Bax G(-248) A (rs4645878) (P=0.002). The risk of metastasis was 11 times with this genotype. It was associated with 6 times more risk of having a tumor larger than 2 cm. The risk of breast cancer was 2.77 times more in individuals carrying the Met/Met genotype of XRCC3 Thr241Met (rs861539) (P=0.009). The risk of having advanced clinical stage (stage III+IV) with the Met/Met genotype was 4 times more increased. No relationship with breast cancer was found with XRCC4 G(-1394) T (rs6869366) and BCL2 C(-938) A (rs2279115) gene polymorphisms. Conclusion. Multicenter trials using subjects with genetic variations are needed to establish the relationship between breast cancer and single gene polymorphism.
format Article
id doaj-art-b6aa6a93a9fb4c668f076f42d73b27b4
institution Kabale University
issn 2090-3189
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Breast Cancer
spelling doaj-art-b6aa6a93a9fb4c668f076f42d73b27b42025-02-03T05:57:20ZengWileyInternational Journal of Breast Cancer2090-31892022-01-01202210.1155/2022/5817841Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast CancerEmre Ozoran0Fadime Didem Can Trabulus1Duygu Erhan2Bahadir Batar3Mehmet Guven4Department of General SurgeryDepartment of General SurgeryDepartment of Medical BiologyDepartment of Medical BiologyDepartment of Medical BiologyBackground. Breast cancer is the most common malignancy in women. Genetic risk factors associated with breast cancer incidence have been identified. Aims. This study is aimed at determining the association of XRCC3 Thr241Met (rs861539), XRCC4 G(-1394) T (rs6869366) DNA repair and BAX G(-248) A (rs4645878), and BCL2 C(-938) A (rs2279115) apoptotic gene polymorphisms with breast cancer. Materials and Methods. Genetic analysis was performed using peripheral blood samples. Gene polymorphisms were detected by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. 175 patients and 158 healthy controls were enrolled in the study. Results. Breast cancer risk was 5.43 times more in individuals with AA genotype of Bax G(-248) A (rs4645878) (P=0.002). The risk of metastasis was 11 times with this genotype. It was associated with 6 times more risk of having a tumor larger than 2 cm. The risk of breast cancer was 2.77 times more in individuals carrying the Met/Met genotype of XRCC3 Thr241Met (rs861539) (P=0.009). The risk of having advanced clinical stage (stage III+IV) with the Met/Met genotype was 4 times more increased. No relationship with breast cancer was found with XRCC4 G(-1394) T (rs6869366) and BCL2 C(-938) A (rs2279115) gene polymorphisms. Conclusion. Multicenter trials using subjects with genetic variations are needed to establish the relationship between breast cancer and single gene polymorphism.http://dx.doi.org/10.1155/2022/5817841
spellingShingle Emre Ozoran
Fadime Didem Can Trabulus
Duygu Erhan
Bahadir Batar
Mehmet Guven
Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
International Journal of Breast Cancer
title Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
title_full Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
title_fullStr Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
title_full_unstemmed Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
title_short Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
title_sort association of xrcc3 xrcc4 bax and bcl 2 polymorphisms with the risk of breast cancer
url http://dx.doi.org/10.1155/2022/5817841
work_keys_str_mv AT emreozoran associationofxrcc3xrcc4baxandbcl2polymorphismswiththeriskofbreastcancer
AT fadimedidemcantrabulus associationofxrcc3xrcc4baxandbcl2polymorphismswiththeriskofbreastcancer
AT duyguerhan associationofxrcc3xrcc4baxandbcl2polymorphismswiththeriskofbreastcancer
AT bahadirbatar associationofxrcc3xrcc4baxandbcl2polymorphismswiththeriskofbreastcancer
AT mehmetguven associationofxrcc3xrcc4baxandbcl2polymorphismswiththeriskofbreastcancer